May 28, 2024
Macrophage marker Market

The Macrophage marker Market Growth is Driven by Increasing Incidence of Cancer

Macrophages play a crucial role in innate immunity and are known to be involved in several physiological and pathological processes such as development, tissue remodeling, metabolism, inflammation and cancer. Macrophage markers are molecules that are expressed on the surface of macrophages and are used by researchers to identify and characterize macrophage subsets and functions. Macrophage markers are gaining immense importance in cancer research for applications such as diagnostic marker identification, determining cancer progression and predicting treatment response.

The global Macrophage Marker Market is estimated to be valued at US$ 295.15 Mn in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period 2023 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Key Trends:

One of the key trends spurring growth in the macrophage marker market size is the rising incidence and prevalence of cancer globally. According to the World Cancer Research Fund International, in 2020, there were an estimated 19.3 million new cancer cases and 10 million cancer deaths. Macrophage markers play an important role during tumorigenesis and tumor progression by interacting with cancer cells, regulating inflammation and remodeling tumor microenvironment. For instance, CD163, CD206 and CD204 markers have been associated with tumor-associated macrophages that promote cancer cell invasion, metastasis and immunosuppression. Increased understanding of macrophage heterogeneity and plasticity is driving research to target specific macrophage subsets as a potential anti-cancer therapy using macrophage markers.

Porter’s Analysis
Threat of new entrants: Low barrier to entry but high costs associated with R&D as well as established brand loyalty.
Bargaining power of buyers: Moderate bargaining power due to presence of substitute products and differentiated nature of products.
Bargaining power of suppliers: High bargaining power due to specialized supplies required and differentiated products.
Threat of new substitutes: Low threat as minimal substitute products currently available however development of new substitutes remains a threat.
Competitive rivalry: Intense competition between existing players to gain higher market share.

Key Takeaways

The global Macrophage Marker market is expected to witness high growth. The global Macrophage Marker Market is estimated to be valued at US$ 295.15 Mn in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period 2023 to 2031.

The North America region is expected to dominate the global macrophage marker market during the forecast period. Factors such as growing healthcare expenditure, presence of key players, increasing R&D activities etc. are expected to boost market growth in the region. The Asia Pacific region is anticipated to exhibit the fastest growth rate over the forecast period owing to growing geriatric population, rising healthcare awareness etc.

Key players operating in the Macrophage Marker market are Thermo Fisher Scientific, Merck, Abcam, Bio-Rad Laboratories, Roche, BD Biosciences. Thermo Fisher Scientific is one of the leading players in the market and offers a wide range of macrophage markers for applications in research and clinical diagnostics.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it